DeepMed Research

University of Virginia

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1819-01-01

Employees: 10K

Market Cap: -

Website: http://www.virginia.edu

Clinical Trials

A Prospective Trial of COXEN Chemotherapy Prediction

Not Applicable

Withdrawn

Conditions: Ovarian Neoplasms
Fallopian Tube Neoplasms

Interventions: Device: COXEN analysis for chemotherapy prediction

First Posted Date: 2010-10-27

Last Posted Date: 2014-06-06

Lead Sponsor: University of Virginia

Registration Number: NCT01228942

IRB-HSR# 14296 The Use of the Intrathoracic Pressure Regulator (ITPR) to Improve Systemic Blood Pressure in Patient Undergoing CABG Surgery

Phase 2

Completed

Conditions: Coronary Artery Disease

Interventions: Device: ITPR

First Posted Date: 2010-09-20

Last Posted Date: 2011-08-10

Lead Sponsor: University of Virginia

Target Recruit Count: 20

Registration Number: NCT01205594

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

IRB-HSR# 14299: The Use of the Intrathoracic Pressure Regulator (ITPR) to Improve Cerebral Perfusion Pressure in Patients With Altered Intracranial Elastance

Phase 2

Conditions: Traumatic Brain Injury

Interventions: Device: ITPR -5 mm Hg then -9 mm Hg
Device: ITPR -9 & then -5mm Hg

First Posted Date: 2010-09-20

Last Posted Date: 2010-09-20

Lead Sponsor: University of Virginia

Target Recruit Count: 20

Registration Number: NCT01205607

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery

Phase 2

Conditions: CABG

Interventions: Other: No intervention
Device: ITPR

First Posted Date: 2010-09-20

Last Posted Date: 2010-09-20

Lead Sponsor: University of Virginia

Target Recruit Count: 30

Registration Number: NCT01205620

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction

Phase 3

Completed

Conditions: Scoliosis

Interventions: Drug: methadone

First Posted Date: 2010-09-20

Last Posted Date: 2016-03-03

Lead Sponsor: University of Virginia

Target Recruit Count: 11

Registration Number: NCT01205256

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

Medications Development for the Treatment of Cannabis Related Disorders

Phase 1

Completed

Conditions: Cannabis Abuse
Nicotine Withdrawal
Marijuana Dependence
Cannabis Dependence
Nicotine Dependence

Interventions: Drug: Placebo Aprepitant
Drug: Active Aprepitant

First Posted Date: 2010-09-17

Last Posted Date: 2012-06-01

Lead Sponsor: University of Virginia

Target Recruit Count: 63

Registration Number: NCT01204723

Locations: 🇺🇸
Clinical Pharmacological Research Unit (CPRU), University of Virginia School of Medicine, Charlottesville, Virginia, United States
🇺🇸
University of Virginia Center for Addiction Education and Treatment (UVA CARE), Charlottesville, Virginia, United States

IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Placebo
Drug: Lidocaine

First Posted Date: 2010-09-17

Last Posted Date: 2022-03-24

Lead Sponsor: University of Virginia

Target Recruit Count: 78

Registration Number: NCT01204242

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

HydroCoil Cerebral Aneurysm Treatment Trial

Phase 4

Terminated

Conditions: Intracerebral Aneursym

Interventions: Device: Non-hydrogel coils
Device: MicroVention Hydrogel coil

First Posted Date: 2010-09-03

Last Posted Date: 2014-12-12

Lead Sponsor: University of Virginia

Target Recruit Count: 215

Registration Number: NCT01195129

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Saint Louis University, St. Louis, Missouri, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States

and more 8 locations

Safety and Efficacy of Rasagiline in Restless Legs Syndrome

Phase 2

Terminated

Conditions: Restless Legs Syndrome

Interventions: Drug: placebo (sugar pill)
Drug: rasagiline

First Posted Date: 2010-09-01

Last Posted Date: 2013-02-11

Lead Sponsor: University of Virginia

Target Recruit Count: 52

Registration Number: NCT01192503

Locations: 🇺🇸
University of Pennsylvania Sleep Center, Philadelphia, Pennsylvania, United States
🇺🇸
SUNY- Buffalo Jacobs Neurological Institute, Buffalo, New York, United States
🇺🇸
Medical College of Georgia Movements Disorders Program, Augusta, Georgia, United States

and more 5 locations

Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer

Conditions: Ovarian Cancer

First Posted Date: 2010-08-24

Last Posted Date: 2014-12-05

Lead Sponsor: University of Virginia

Target Recruit Count: 103

Registration Number: NCT01187602

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy